Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Edwards Lifesciences (EW) PT Raised to $118 at Stifel
April 26, 2017 8:36 AM EDTStifel raised its price target on Edwards Lifesciences (NYSE: EW) to $118.00 (from $114.00) while maintaining a Buy rating. 1Q17 EPS of $0.94 beat consensus projections by $0.12. The quarters impressive EPS beat was driven by broad based top-line outperformance across the companys product lines and... More
